Across TCGA pan-cancer cohorts, HNRNPA1P46 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of HNRNPA1P46’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where HNRNPA1P46 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types HNRNPA1P46 is over-expressed in tumor.
LUAD, STAD, and COAD are the cancer types where HNRNPA1P46 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in HNRNPA1P46 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.